1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998-2009: a large population study
- PMID: 24128415
- DOI: 10.1016/j.jhep.2013.09.027
1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998-2009: a large population study
Abstract
Background & aims: Large, population-based studies that have included the full spectrum of cirrhosis estimating survival, taking into account time-at-risk are lacking. We aimed to report 1- and 5-year average survival rates for people with cirrhosis to be used in a clinical and healthcare policy setting.
Methods: We used the Clinical Practice Research Datalink and linked English Hospital Episode Statistics to identify adult cases of cirrhosis from January 1998 to December 2009. We estimated 1- and 5-year survival according to whether time-at-risk was ambulatory or followed an emergency hospital admission related to liver disease, stratified by age, sex, and aetiology to be used in a clinical setting. We used a multivariate Cox-proportional hazards model with a time-varying variable, adjusted for Baveno IV stage of cirrhosis at diagnosis, age, aetiology, and sex.
Results: We identified 5118 incident cases. Average survival probabilities at 1- and 5-years were 0.84 (95% CI 0.83-0.86) and 0.66 (95% CI 0.63-0.68) for the ambulatory group and 0.55 (95% CI 0.53-0.57) and 0.31 (95% CI 0.29-0.33) following hospitalisation, respectively. A hospital admission at diagnosis or subsequently for liver disease substantially impaired prognosis independent of stage of cirrhosis (HR=2.78, 95% CI 2.53, 3.06).
Conclusions: Emergency hospitalisation for liver disease heralds a downturn in a patient's outlook independent of their stage of cirrhosis. Our results provide population-based clinically translatable estimates of prognosis for the purposes of healthcare delivery and planning and communication to patients.
Keywords: Aetiology; CPRD; Cirrhosis; Clinical Practise Research Datalink; HES; Hospital Episode Statistics; ICD10; International Classification of Disease 10th version; ONS; OPCS4; Office of National Statistics; Office of Population Censuses and Surveys’ classification of interventions and procedures 4th version; Population-based; Survival; UTS; up to standard.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Comment in
-
The clinical course of cirrhosis. Population based studies and the need of personalized medicine.J Hepatol. 2014 Feb;60(2):241-2. doi: 10.1016/j.jhep.2013.10.023. Epub 2013 Nov 6. J Hepatol. 2014. PMID: 24211741 No abstract available.
Similar articles
-
Causes of death in people with liver cirrhosis in England compared with the general population: a population-based cohort study.Am J Gastroenterol. 2015 Aug;110(8):1149-58. doi: 10.1038/ajg.2015.191. Epub 2015 Jul 14. Am J Gastroenterol. 2015. PMID: 26169512
-
All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study.Liver Int. 2012 Jan;32(1):79-84. doi: 10.1111/j.1478-3231.2011.02517.x. Epub 2011 Apr 6. Liver Int. 2012. PMID: 21745279
-
The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC).PLoS One. 2019 Oct 3;14(10):e0223253. doi: 10.1371/journal.pone.0223253. eCollection 2019. PLoS One. 2019. PMID: 31581237 Free PMC article.
-
Mortality from cirrhosis: lack of progress over the last 35 years.Gut. 2005 Nov;54(11):1523-6. doi: 10.1136/gut.2005.072876. Gut. 2005. PMID: 16227356 Free PMC article. Review. No abstract available.
-
Increasing pharmacoequity for people with cirrhosis.Clin Liver Dis (Hoboken). 2024 Jun 7;23(1):e0203. doi: 10.1097/CLD.0000000000000203. eCollection 2024 Jan-Jun. Clin Liver Dis (Hoboken). 2024. PMID: 38860125 Free PMC article. Review. No abstract available.
Cited by
-
Alcoholic liver disease - the extent of the problem and what you can do about it.Clin Med (Lond). 2015 Apr;15(2):179-85. doi: 10.7861/clinmedicine.15-2-179. Clin Med (Lond). 2015. PMID: 25824072 Free PMC article. Review.
-
Health Technology Adoption in Liver Disease: Innovative Use of Data Science Solutions for Early Disease Detection.Front Digit Health. 2022 Jan 28;4:737729. doi: 10.3389/fdgth.2022.737729. eCollection 2022. Front Digit Health. 2022. PMID: 35156081 Free PMC article.
-
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C.World J Gastroenterol. 2020 Jan 14;26(2):109-133. doi: 10.3748/wjg.v26.i2.109. World J Gastroenterol. 2020. PMID: 31969775 Free PMC article. Review.
-
Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.J Viral Hepat. 2021 Aug;28(8):1177-1189. doi: 10.1111/jvh.13545. Epub 2021 Jun 8. J Viral Hepat. 2021. PMID: 34003542 Free PMC article.
-
The Impact of SARS-CoV-2 on the Most Common Comorbidities-A Retrospective Study on 814 COVID-19 Deaths in Romania.Front Med (Lausanne). 2020 Sep 9;7:567199. doi: 10.3389/fmed.2020.567199. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33015111 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical